Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Square Brussels Convention Centre

Mar 12, 2024 9:00 AM - Mar 14, 2024 4:00 PM

Glass Entrance, Mont des Arts/Kunstberg, 1000 Brussels, Belgium

DIA Europe 2024

Deep Dive into the Impact of the New Pharmaceutical Legislation on Regulatory Operations: The Impact on Data, Technology, and Processes in Regulatory Affairs

Session Chair(s)

Remco  Munnik

Remco Munnik

President

IRISS Forum, Spain

Building on the DIAmond session planned on the topic of ‘The New Pharmaceutical Legislation’ - This session will deep dive into its impact on Regulatory Operations; highlighting the role of automation and interoperability within regulatory affairs in Europe and how sector hopes to achieve regulatory efficiency from the process, data and technology point of view. The session will also be complemented by sharing a case study that will deep dive into electronic product information to address what is perceived as missing both from a content and technical point of view.

Learning Objective : After this session, participants should recognize the impact of the implementation of the new EU pharmaceutical legislation on Regulatory Affairs. Be able to describe and discuss the impact on internal processes and systems, while analyzing priorities and decide on crucial initiatives of the company´s Regulatory strategy

Speaker(s)

Remco  Munnik

New Pharmaceutical Legislation: The Impact on Data, Technology, and Processes in Regulatory Affairs

Remco Munnik

IRISS Forum, Spain

President

Juan  Garcia-Burgos, MD, PhD

Impact of the New Pharmaceutical Legislation on EMA's Strategy and Roadmap

Juan Garcia-Burgos, MD, PhD

European Medicines Agency, Netherlands

Head of Public and Stakeholders Engagement Department

Vada A. Perkins, DrSc, MSc

Impact on Industry's Regulatory Operations Systems and Processes

Vada A. Perkins, DrSc, MSc

Boehringer Ingelheim, United States

Vice President, Global Head of Regulatory Intelligence & Policy

Paul-Etienne  Schaeffer, PharmD

Building a Healthier and Empowered Society: Package Leaflet Content Well-Needed Improvements

Paul-Etienne Schaeffer, PharmD

AESGP, Belgium

Life Sciences Regulatory Affairs Manager

Julie  Spony, MA

Panelist

Julie Spony, MA

European Patients' Forum, Belgium

Policy Officer

Elizabeth  Scanlan, PhD, MSc

Panelist

Elizabeth Scanlan, PhD, MSc

European Medicines Agency, Netherlands

ePI Product Owner

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.